Privia Health Group Inc(PRVA) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 30 at 4:00 PM ET (Korea 10/31 05:00)
Full metrics table
| Index | RUT | P/E | 99.68 | EPS (ttm) | 0.22 | Insider Own | 7.11% | Shs Outstand | 126.3M | Perf Week | -4.15% |
| Market Cap | 2.74B | Forward P/E | 51.49 | EPS next Y | 61.99% | Insider Trans | -6.34% | Shs Float | 118.7M | Perf Month | 7.24% |
| Enterprise Value | 2.40B | PEG | 1.1 | EPS next Q | 0.09 | Inst Own | 88.42% | Short Float | 4.22% | Perf Quarter | -9.71% |
| Income | 0.03B | P/S | 1.16 | EPS this Y | 43.08% | Inst Trans | -2.22% | Short Ratio | 4.08 | Perf Half Y | -13.56% |
| Sales | 2.36B | P/B | 3.47 | EPS next 5Y | 46.98% | ROA | 2.04% | Short Interest | 5.01M | Perf YTD | -9.41% |
| Book/sh | 6.19 | P/C | 6.66 | EPS past 3/5Y | - -9.67% | ROE | 3.84% | 52W High | -25.47% ($28.82) | Perf Year | -12.36% |
| Cash/sh | 3.23 | P/FCF | 21.13 | Sales past 3/5Y | 16.1% 21.04% | ROIC | 3.56% | 52W Low | 13.56% ($18.92) | Perf 3Y | 3.92% |
| Dividend Est. | - | EV/EBITDA | 42.08 | EPS Y/Y TTM | 84.08% | Gross Margin | 9.52% | Volatility(W/M) | 2.74% 2.71% | Perf 5Y | -16.42% |
| Dividend TTM | - | EV/Sales | 1.02 | Sales Y/Y TTM | 24.1% | Oper. Margin | 1.9% | ATR (14) | 0.61 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.62 | EPS Q/Q | 228.23% | Profit Margin | 1.19% | RSI (14) | 48.92 | Recom | 1.17 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.62 | Sales Q/Q | 21.39% | SMA20 | -1.11% ($21.72) | Beta | 0.78 | Target Price | $31.47 |
| Payout | - | Debt/Eq | 0.01 | Earnings | 2026/11/5 | SMA50 | 2.88% ($20.88) | Rel Volume | 0.69 | Prev Close | $22 |
| Employees | 1226 | LT Debt/Eq | 0.01 | EPS/Sales Surpr. | 3.86% 5.91% | SMA200 | -5.24% ($22.67) | Avg Volume(3M) | 1.23M | Price | $21.48 |
| IPO | 2021/4/29 | Option/Short | Yes/Yes | Trades | 9869 | Volume | 840,971 | Change | -2.34% |
A U.S. healthcare services company that provides a physician practice support platform. It offers physicians and medical groups a platform that supports clinical operations and value-based care, with exposure to expanding medical networks and the shift toward value-based care. The company operates in the physician practice support platform space.
Over the past 1 year, roughly in the middle
25% below its 1-year high.
Traded less than usual. That is 69% of its average volume.
Next earnings report: November 5
5 days to go.
PRVA earns at a steady pace
Of every $100 in sales, $1.90 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +43.1% this year.
Tap to view numbers
However, it looks expensive
For a company earning $100 a year, you would pay $9,968. Peers typically go for $4,849. Compared with its own 3-year average, it is 21% cheaper now.
Tap to view numbers
Results came in about as expected
Mixed beats and misses
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -16.4%. The S&P 500 did +65% over the same period.
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Ownership looks stable
Institutions hold 88.4%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #9 of 41 in the industry
Based on market cap of $3B.
PRVA#9 Privia Health Group Inc $3B PER 99.7 
SDGR#10 Schrodinger Inc $2B PER - 
CERT#11 Certara Inc $2B PER - 
OMCL#12 Omnicell Inc $2B PER 38.0 
TDOC#13 Teladoc Health Inc $2B PER - 
FAQ
What kind of company is PRVA?
PRVA belongs to the Healthcare sector and operates in the Health Information Services industry.
What is the market cap of PRVA?
The market cap of PRVA is approximately $2.7B, ranking 1,822 within its sector.
What is the P/E ratio of PRVA?
PRVA has a P/E ratio of approximately 99.7x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for PRVA?
PRVA has recorded a 52-week high of $28.82 and a low of $18.92.
